Related Experiment Video
Updated: Apr 26, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Is tenofovir/emtricitabine teratogenic?
Murtala Jibril1, Oluwaseun Egunsola2
1Department of Pharmacology, Faculty of Medicine, Bayero University Kano, Kano State, Nigeria and Alnoury Hospital, Kano, Kano State, Nigeria.
The Truvada(®) (tenofovir/emtricitabine) and nevirapine combination is increasingly being prescribed for prevention of mother-to-child HIV transmission. There is presently no documented evidence of teratogenicity of either tenofovir/emtricitabine or nevirapine. We report two cases of spina bifida in infants of mothers on this drug combination.
The Truvada(®) (tenofovir/emtricitabine) and nevirapine combination is increasingly being prescribed for prevention of mother-to-child HIV transmission. There is presently no documented evidence of teratogenicity of either tenofovir/emtricitabine or nevirapine. We report two cases of spina bifida in infants of mothers on this drug combination.
Related Concept Videos
Teratogenicity
Retroviruses
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Inhibitors of Viral Protein Synthesis
Mutagenicity and Carcinogenicity
Non-LTR Retrotransposons

